EQT agrees to majority stake in clinical trial software developer CluePoints
Summit Partners and other existing shareholders are reinvesting in the Belgian business, which has an office outside Philadelphia.
Summit Partners and other existing shareholders are reinvesting in the Belgian business, which has an office outside Philadelphia.